Several of the previously mentioned target pathways in TNBC have been associated with EMT mechanisms, maintenance of tumor-initiating cells and/or tumor invasion, and drug resistance, including AR, ADR, STAT3, and AXL pathways. This evidence concerns the gene AXL and neoplasm.